| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| FMR LLC | 10.1% | -30% | $33.8M | -$14.1M | 11.1M | -29.4% | FMR LLC | Sep 30, 2025 |
| VANGUARD GROUP INC | 5.31% | +8.2% | $17.8M | $1.39M | 5.84M | +8.47% | The Vanguard Group | Sep 30, 2025 |
| Bain Capital Life Sciences Fund, L.P. | 4.9% | $7.24M | 5.25M | BCLS I Investco, LP | Dec 31, 2024 | |||
| Point72 Asset Management, L.P. | 0.1% | $132K | 95.4K | Point72 Asset Management, L.P. | Mar 31, 2025 |
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Change | Price | Investors |
|---|---|---|---|---|---|
| 2025 Q3 | 101M | $309M | +$11.2M | $3.05 | 141 |
| 2025 Q2 | 99.4M | $239M | +$760K | $2.40 | 127 |
| 2025 Q1 | 99.5M | $192M | -$14.2M | $1.93 | 146 |
| 2024 Q4 | 112M | $574M | +$7.29M | $5.13 | 151 |
| 2024 Q3 | 110M | $651M | +$12.1M | $5.92 | 141 |
| 2024 Q2 | 107M | $526M | +$50.6M | $4.90 | 142 |
| 2024 Q1 | 94.8M | $679M | +$103M | $7.17 | 126 |
| 2023 Q4 | 19.1K | $86.6K | -$10.9K | $4.54 | 1 |
| 2023 Q3 | 53.3M | $126M | -$902K | $2.36 | 91 |
| 2023 Q2 | 53.4M | $188M | -$1.7M | $3.52 | 93 |
| 2023 Q1 | 54M | $208M | +$10.8M | $3.85 | 96 |
| 2022 Q4 | 47M | $243M | +$3.51M | $5.17 | 81 |
| 2022 Q3 | 46.3M | $286M | +$50.2M | $6.18 | 68 |
| 2022 Q2 | 37.3M | $141M | +$11.7M | $3.77 | 70 |
| 2022 Q1 | 35.6M | $97.2M | -$20.2M | $2.73 | 91 |
| 2021 Q4 | 38.2M | $439M | +$3.77M | $11.49 | 90 |
| 2021 Q3 | 38.1M | $709M | -$28M | $18.61 | 81 |
| 2021 Q2 | 38.8M | $871M | +$28.3M | $22.51 | 73 |
| 2021 Q1 | 37.4M | $1.04B | +$36.7M | $27.84 | 72 |
| 2020 Q4 | 35M | $873M | -$19.1M | $25.03 | 68 |
| 2020 Q3 | 34.8M | $1.04B | +$1.04B | $30.23 | 65 |